Janus Henderson Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Janus Henderson Group's IRMD Position: Q1 2026 in Review
Janus Henderson Group held its iRadimed (IRMD) position steady in Q1 2026 at 3,100 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.
Janus Henderson Group first reported a position in IRMD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.86M in Q4 2023. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Janus Henderson Group held 3,100 shares of iRadimed worth $298K as of Q1 2026.
- Janus Henderson Group left its iRadimed share count unchanged in Q1 2026.
- iRadimed made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2217 holding.
- Janus Henderson Group first reported a position in iRadimed in Q2 2020 and has held it in 12 quarters since.
- Janus Henderson Group's iRadimed position peaked at $1.86M in Q4 2023.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.